Catalyst Wire Dossier Catalyst Wire Dossier

Phentolamine Ophthalmic Solution

phentolamine · Ocuphire Pharma, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Phentolamine Ophthalmic Solution, covering 2025-10-01 to 2026-06-22. Get the full timeline:

Most recent: Clinical Trial Update: OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity [Phase 3]

See pricing